journal article·2016-10Open access

Valve interstitial cell tensional homeostasis directs calcification and extracellular matrix remodeling processes via RhoA signaling

Emily J. Farrar, Varsha Pramil, Jennifer M. Richards, Christopher Z. Mosher, Jonathan T. Butcher

Biomaterials· Volume 105

Abstract

Aims Valve interstitial cells are active and aggressive players in aortic valve calcification, but their dynamic mediation of mechanically-induced calcific remodeling is not well understood. The goal of this study was to elucidate the feedback loop between valve interstitial cell and calcification mechanics using a novel three-dimensional culture system that allows investigation of the active interplay between cells, disease, and the mechanical valve environment. Methods & results We designed and characterized a novel bioreactor system for quantifying aortic valve interstitial cell contractility in 3-D hydrogels in control and osteogenic conditions over 14 days. Interstitial cells demonstrated a marked ability to exert contractile force on their environment and to align collagen fibers with the direction of tension. Osteogenic environment disrupted interstitial cell contractility and led to disorganization of the collagen matrix, concurrent with increased αSMA, TGF-β, Runx2 and calcific nodule formation. Interestingly, RhoA was also increased in osteogenic condition, pointing to an aberrant hyperactivation of valve interstitial cells mechanical activity in disease. This was confirmed by inhibition of RhoA experiments. Inhibition of RhoA concurrent with osteogenic treatment reduced pro-osteogenic signaling and calcific nodule formation. Time-course correlation analysis indicated a significant correlation between interstitial cell remodeling of collagen fibers and calcification events. Conclusions Interstitial cell contractility mediates internal stress state and organization of the aortic valve extracellular matrix. Osteogenesis disrupts interstitial cell mechanical phenotype and drives disorganization, nodule formation, and pro-calcific signaling via a RhoA-dependent mechanism.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cardiac Valve Diseases and Treatments · Parathyroid Disorders and Treatments · Aortic Disease and Treatment Approaches

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (47)

Show source-provided references
1. Heart disease and stroke statistics - 2015 update
2. Calcific aortic valve disease: not simply a degenerative process10.1161/CIRCULATIONAHA.110.006767 ↗
3. Clinical factors associated with calcific aortic valve disease10.1016/S0735-1097(96)00563-3 ↗
4. Prevention of calcific aortic valve stenosis—fact or fiction?10.1080/07853890802331394 ↗
5. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies10.1161/CIRCULATIONAHA.104.486738 ↗
6. Localization and pattern of expression of extracellular matrix components in human heart valves
7. Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues10.1161/CIRCRESAHA.110.234237 ↗
8. Mechanobiology of the aortic heart valve
9. The cardiac valve interstitial cell10.1016/S1357-2725(02)00100-0 ↗
10. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology10.2353/ajpath.2007.070251 ↗
11. Synergistic effects of cyclic tension and transforming growth factor-β1 on the aortic valve myofibroblast10.1016/j.carpath.2007.03.006 ↗
12. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease10.1161/01.RES.0000136520.07995.aa ↗
13. Calcific nodule morphogenesis by heart valve interstitial cells is strain dependent10.1007/s10237-012-0377-8 ↗
14. Aortic valve cyclic stretch causes increased remodeling activity and enhanced serotonin receptor responsiveness10.1016/j.athoracsur.2011.03.084 ↗
15. Cyclic strain anisotropy regulates valvular interstitial cell phenotype and tissue remodeling in three-dimensional culture10.1016/j.actbio.2012.01.006 ↗
16. Elevated cyclic stretch alters matrix remodeling in aortic valve cusps: implications for degenerative aortic valve disease10.1152/ajpheart.00900.2008 ↗
17. The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops10.1016/j.carpath.2012.06.005 ↗
18. Manipulation of valve composition to elucidate the role of collagen in aortic valve calcification10.1186/1471-2261-14-29 ↗
19. Determination of local and global elastic moduli of valve interstitial cells cultured on soft substrates10.1016/j.jbiomech.2013.05.001 ↗
20. A novel mouse model of aortic valve stenosis induced by direct wire injury10.1161/ATVBAHA.113.302610 ↗
21. Tumor necrosis factor-α accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway10.1124/jpet.110.177915 ↗
22. Endothelial-derived oxidative stress drives myofibroblastic activation and calcification of the aortic valve10.1371/journal.pone.0123257 ↗
23. 3D bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels10.1002/jbm.a.34420 ↗
24. Self-assembly of aligned tissue-engineered annulus fibrosus and intervertebral disc composite via collagen gel contraction10.1089/ten.tea.2009.0442 ↗
25. Myocyte-depleted engineered cardiac tissues support therapeutic potential of mesenchymal stem cells10.1089/ten.tea.2011.0278 ↗
26. Differences in valvular and vascular cell responses to strain in osteogenic media10.1016/j.biomaterials.2011.01.030 ↗
27. Assaying stem cell mechanobiology on microfabricated elastomeric substrates with geometrically modulated rigidity10.1038/nprot.2010.189 ↗
28. Myofibroblast persistence with real-time changes in boundary stiffness10.1016/j.actbio.2015.12.031 ↗
29. Specific regional and directional contractile responses of aortic cusp tissue
30. The effects of cellular contraction on aortic valve leaflet flexural stiffness10.1016/j.jbiomech.2004.11.008 ↗
31. Characterization of porcine aortic valvular interstitial cell “calcified” nodules10.1371/journal.pone.0048154 ↗
32. Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner10.2353/ajpath.2010.090631 ↗
33. Contractility as a prerequisite for TGF-β -induced myofibroblast transdifferentiation in human tenon fibroblasts10.1167/iovs.06-0118 ↗
34. TGF-β signaling and the fibrotic response10.1096/fj.03-1273rev ↗
35. TGF-β1 diminishes collagen production during long-term cyclic stretching of engineered connective tissue Implication of decreased ERK signaling10.1016/j.jbiomech.2010.12.007 ↗
36. Transforming growth factor-β1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events10.1016/j.athoracsur.2006.10.026 ↗
37. Progression of aortic valve stenosis: TGF-β1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis10.1016/S0003-4975(02)04312-6 ↗
38. The effects of dexamethasone, ascorbic acid, and b-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression10.1016/j.jss.2010.09.010 ↗
39. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation10.1002/jbmr.313 ↗
40. Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C1210.1128/MCB.20.23.8783-8792.2000 ↗
41. Inhibitory role of Notch1 in calcific aortic valve disease10.1371/journal.pone.0027743 ↗
42. Reduced Sox9 function promotes heart valve calcification phenotypes10.1161/CIRCRESAHA.109.213702 ↗
43. Mechanical strain induces the production of spheroid mineralized microparticles in the aortic valve through a RhoA/ROCK-dependent mechanism10.1016/j.yjmcc.2013.12.009 ↗
44. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors10.1093/eurheartj/ehi248 ↗
45. Cellular mechanisms of aortic valve calcification10.1161/CIRCINTERVENTIONS.112.971028 ↗
46. Extracellular matrix remodeling and organization in developing and diseased aortic valves10.1161/01.RES.0000224114.65109.4e ↗
47. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix10.1161/ATVBAHA.108.182394 ↗